GL PharmTech announced on May 28 that it will merge its subsidiary, GL Pharma, through absorption.



GL PharmTech owns 100% of the shares in GL Pharma. The purpose of the merger is to "enhance management efficiency and strengthen business competitiveness."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing